NLRP3 and hepatocellular carcinoma: Wei et al. (24) showed that E2 impedes HCC growth through the promotion of the NLRP3 inflammasome via activating the ERβ/MAPK/ERK pathway in human primary HCC samples and human HCC cell lines, including HepG2 cell lines, among others.